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Abstract Ascorbic acid synthesis was stimulated by glucagon, dibutyryl cyclic AMP, as well as phenylephrine, vasopressin or okadaic acid, in 
hepatocytes prepared from fed mice. However, no such effect was observed in glycogen-depleted c lls from starved animals, either in the presence 
or absence of glucose. The rate of ascorbate synthesis showed close correlation with the glucose release by hepatocytes. In mice the injection of 
glucagon increased plasma ascorbate concentration fifteenfold, and caused a sixfold elevation of the ascorbate content of the liver. These results show 
that hepatic ascorbate synthesis is dependent on glycogenolysis, and indicate a regulatory role of ascorbate released by the liver. 
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1. Introduction 
Ascorbic acid is involved in the antioxidant defence of the 
cell: it is connected to glutathione reduction, participates in free 
radical scavenging as an antioxidant, and also plays an impor- 
tant role in biosynthetic processes, such as collagen and cate- 
cholamine synthesis [l-3]. Despite the important functions of 
ascorbic acid, relatively few data are available on the regulation 
of its biosynthesis. Ascorbate is produced in many plants, mi- 
croorganisms and animals, except for primates and guinea pig. 
In animals ascorbic acid is synthesized from UDP-glucuronic 
acid in the uranic acid pathway in the liver and kidney. Previ- 
ously we have shown that the substrate supply of another UDP- 
glucuronic acid-consuming process, glucuronidation, is 
furnished by glycogenolysis and not gluconeogenesis [4,5]. 
Furthermore, we have suggested a coordinated regulation of 
glycogenolysis and glucuronide conjugation: the stimulation of 
glycogenolysis has been accompanied with the inhibition of 
glucuronide conjugation by various agents acting via CAMP or 
Ca”-dependent mechanisms [&9]. Knowing all this, experi- 
ments were undertaken to investigate the connection between 
glycogen metabolism and ascorbate formation. Our results 
show that in mouse liver, ascorbate production can be en- 
hanced via stimulated glycogenolysis in both in vivo and in 
vitro in isolated hepatocytes. 
2. Experimental 
2.1. Materials 
Collagenase (type IV), a,a’dipyridyl, o-dianisidine, glucose oxidase, 
okadaic acid, phenylephrine ]Arg*]-vasopressin and dibutyryl cyclic 
AMP were bought-from Sigma, St. Louis, MO, USA. Horseradish 
peroxidase was purchased from Reanal Fine Chemicals, Budapest, 
Hungary. Glucagon was received from Novo Nordisk A/S 2880 
Bagsvaerd, Denmark. All other chemicals were of analytical grade. 
2.2. Blood samples and liver tissue preparation from in vivo glucagon- 
treated mice 
Male CFLP mice (30-40 g body weight) fed ad hbitum were used. 
100 &kg glucagon was administered to animals intraperitoneally in a 
final volume of 1 ml isotonic saline. The control group received 1 ml 
of isotonic saline. The mice were sacrificed 15 min after the injection. 
Blood samples for determination of blood glucose and plasma ascorbic 
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acid were obtained after Nembutal anaesthesia by puncture of the 
inferior vena cava. The weight of the livers was measured following 
their excision. The livers then were homogenized in cold 5% TCA as 
described by Zannoni et al. [lo]. The final concentration of the liver 
tissue homogenate was about 5%. 
2.3. Preparation and incubation of isolated mouse hepatocytes 
Isolated hepatocytes were prepared with the collagenase perfusion 
method as detailed earlier [l l] from male CFLP mice fed ad libitum or 
starved for 48 h. Viability of the cells checked by the Trypan blue 
exclusion test was more than 90%. Cells were incubated in Krebs- 
Henseleit bicarbonate buffer (pH 7.4) containing 2.5 mM Ca*‘, I % 
albumin, 8.5 mM glucose, 5 mM pyruvate and amino acids (1 mM of 
each) under constant bubbling of gas (OJCO,, 95 : 5, v/v) at 37°C. In 
a series of experiments glucose, pyruvate and amino acids were omitted 
from the incubation medium. Incubations were terminated by the addi- 
tion of two vols. of cold 5% TCA. 
2.4. Metabolite measurements 
Ascorbic acid (reduced form) contents of plasma, liver tissue homo- 
genate and hepatocyte suspension were determined by the dipyridyl 
reaction according to Omaya et al., which relies on the reduction of 
ferric iron by ascorbic acid followed by formation of a complex of the 
ferrous iron product and a,a’-dipyridyl [12]. Blood glucose and the 
glucose production of hepatocytes were determined by the method of 
Bergmeyer and Bemt [13]. 
2.5. Miscellaneous 
DNA content of isolated hepatocytes was measured by the method 
of Burton [14]. Data are expressed as mean ?r S.E.M.; statistical analy- 
sis was performed using Student’s t-test. 
3. Results 
3.1. Ascorbic acid synthesis in isolated mouse hepatocytes: effect 
of agents stimulating glucogenolysis 
The role of the hepatic glycogen content in ascorbic acid 
synthesis was investigated in isolated mouse hepatocytes. The 
cells were prepared from fed or 48 h-starved mice and the 
ascorbic acid content was measured in the suspension 
(cells+medium). After 48 h starvation hepatocytes did not con- 
tain measurable amounts of glycogen. The initial concentration 
of ascorbic acid was lower in the suspension of glycogen-de- 
pleted hepatocytes compared to the fed controls (Fig. 1) and 
only a moderate synthesis could be observed under both nutri- 
tional conditions. The effects of dibutyryl CAMP and glucagon 
on ascorbate synthesis were examined. Glucagon or dibutyryl 
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(Table 2). The concentration of ascorbic acid in the liver was 
also increased, indicating a stimulated hepatic synthesis (Table 2). 
4. Discussion 
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Fig. 1. Effect of glucagon and dibutyryl cyclic AMP on the ascorbic acid 
production of isolated mouse hepatocytes. Hepatocytes (2 x lo6 cells/ 
ml) prepared from fed (filled symbols) or 48 h-starved (open symbols) 
animals were incubated in the presence (continuous lines) or in the 
absence (dashed lines) of glucose, pyruvate and amino acids. The ascor- 
bic acid content of cell suspensions was measured. (w, 0) Control, 
(0, o) 1 mM dibutyryl cyclic AMP, (A, A) 100 nM glucagon. Data are 
means f S.E.M., n = 4-9. 
cyclic AMP caused a stimulation of ascorbic acid synthesis in 
hepatocytes from fed mice, while in hepatocytes from 48 h- 
starved animals ascorbic acid production was not increased 
significantly by the two agents (Fig. 1). The addition of glucose 
and gluconeogenic precursors to the incubation medium did 
not result in a significant increase in ascorbic acid production 
(Fig. 1). 
In another series of experiments glucose and ascorbic acid 
production of the cells was measured simultaneously. The rate 
of glucose production (in the absence of gluconeogenic precur- 
sors mainly via glucogenolysis) and ascorbic acid synthesis 
showed a close correlation (r = 0.9091) (Fig. 2). 
As ascorbic acid synthesis and glycogenolysis eemed to be 
connected, we examined the effect on ascorbic acid synthesis 
of various agents known to increase glycogenolysis. The al 
agonist phenylephrine, the protein phosphatase inhibitor oka- 
daic acid and vasopressin all increased the rate of ascorbic acid 
production in isolated hepatocytes prepared from fed mice sim- 
ilarly to glucagon (Table 1). 
3.2. Effect of giucagon on ascorbic acid synthesis in vivo 
Glycogenolysis was stimulated by the in vivo addition of 
glucagon. Glucagon elevated the blood glucose level of mice 
by 50%; at the same time a more than fifteenfold increase 
of plasma ascorbic acid concentration could be observed 
Glycogen content is considered to be a sensitive marker 
showing the actual metabolic state of the liver. Observations 
described in this paper suggest hat ascorbic acid synthesis in 
murine liver is tightly connected with the glycogen pool; the 
source of ascorbic acid is glycogen. The following results gained 
in isolated hepatocytes upport this assumption: first, in hepa- 
tocytes isolated from glycogen-depleted animals the ascorbic 
acid level as well as the rate of synthesis is lower than that in 
hepatocytes from control fed mice (Fig. 1); second, different 
glycogen-mobilizing agents acting via different mechanisms en- 
hance ascorbic acid production in hepatocytes from fed but not 
from fasted animals (Fig. 1, Table 1); third, addition of glucose 
to hepatocytes prepared from glycogen-depleted mice failed to 
increase the formation of ascorbic acid (Fig. 1). The results 
gained under in vitro conditions in isolated hepatocytes were 
confirmed by in vivo experiments: a single i.p. injection of 
glucagon elevated both the plasma and liver ascorbic acid levels 
within 15 min (Table 2). 
Hepatic regulation of glycogen metabolism affects not only 
the metabolism of glucose, but the availability of several glu- 
cose derivatives as well. Previously it has been shown that 
different conditions in glycogen metabolism, but not that of 
gluconeogenesis, alter the rate of glucuronidation, a UDP-glu- 
curonic acid (thus finally glucose) consuming process. It has 
been suggested that in hepatocytes there are two separate glu- 
cose-6-phosphate pools: one is connected with glycogenolysis 
and another related to gluconeogenesis and glucose uptake 
[l&16]. Our data indicate that (similarly to glucuronidation) 
ascorbic acid production is ascribable to the former pool, and 
in mouse liver it is controlled through the regulation of glyco- 
genolysis. It is noted that besides glycogenolysis a second regu- 
lated step of ascorbate synthesis cannot be excluded [17]. 
The finding that the source of ascorbate production is glyco- 
genolysis is in according with the fact that liver and kidney -the 
main sites of glycogen storage - are responsible for the ascorbic 
acid supply in most animal species [2]. The increased hepatic 
ascorbic acid production after glucagon administration can be 
explained as a compensatory mechanism of the missing intake 
of ascorbate, i.e. adaptation of ascorbic acid supply from exter- 
Table 1 
Ascorbic acid production of isolated mouse hepatocytes after the treat- 
ment with different elvcoeen-mobilizine agents 
Treatment Ascorbic acid production 
(pmohmin per lo6 cells) 
Control 140 f 45 
1 mM dibutyryl CAMP 562 f 96+** 
0.1 PM glucagon 496 f 39** 
1 ,uM okadaic acid 889 f 157*** 
200 nM vasopressin 543 + 46*** 
100 nM phenylephrine 580 f 63*** 
Hepatocytes (2 x IO6 cells/ml) prepared from fed animals were incu- 
bated in the presence of different glycogen-mobilizing agents. The 
ascorbic acid content of the hepatocyte suspension was measured after 
0 and 15 min of incubation. Values are given as means & S.E.M. of 
4 experiments. Significant differences from the control value are indi- 
cated: **P < 0.02, ***P < 0.01. 
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Fig. 2. The relationship between glucose and ascorbic acid production 
of isolated mouse hepatocytes. Cells (2 x IO6 cells/ml) prepared from fed 
(filled symbols) or 48 h-starved (open symbols) animals were incubated 
in the absence of glucose, pyruvate and amino acids. Glucose and 
ascorbic acid production of the cells were measured. Data are partially 
taken from Fig. 1 and Table 1. (a, O) Control, (0, o) 1 mM dibutyryl 
cyclic AMP, (A) 100 nM glucagon. Data are means + S.E.M., n = 4-9. 
nal to internal sources. Considering the fifteenfold elevation of 
plasma ascorbate levels, in the light of recent findings concern- 
ing the effect of ascorbate on insulin secretion [18] and on the 
calcium channels in pancreatic beta cells [19] it might be also 
regarded as a possible intercellular messenger. 
Liver plays a central role in the antioxidant defence of the 
organism, as well. The hepatic glutathione synthesis is essential 
Table 2 
Effect of glucagon on plasma and hepatic ascorbic acid concentrations 
in mice 
Control 100 ,@kg 
glucagon i.p. 
Blood glucose concentration 
(mM) 6.67 ?r 0.11 10.14 f 0.23*** 
Plasma ascorbic acid 
concentration @M) 3.45 _+ 1.21 53.39 f 6.25*** 
Ascorbic acid content of 
the liver @mol/g) 0.58 + 0.15 3.83 f 0.16*** 
1 OO&kg glucagon was administered to mice intraperitoneally ina final 
volume of 1 ml isotonic saline. The control group received 1 ml of 
isotonic saline. The animals were sacrificed 15 min after the injection. 
Blood samples and liver tissue preparation were executed as detailed 
in section 2. The ascorbic acid content of plasma, liver tissue homoge- 
nate and blood glucose concentration were determined. Data are 
means + S.E.M. of 4 experiments. ***Statistically significant differ- 
ence: P < 0.01. 
for maintenance of the inter-organ cycle of this compound. Our 
results suggest that a similar situation exists in the case of 
ascorbate; the ascorbic acid claim of different cells (adrenal 
medulla [3], neutrophil granulocyte [20,21] etc.) is satisfied by 
the hepatic synthesis. The observation that insulin-induced hy- 
poglycemia in vivo causes a rapid depletion of ascorbate in the 
adrenal medulla of rats [3] supports this assumption. The ele- 
vated hepatic ascorbic acid formation upon addition of the 
ancient hunger signal CAMP (Fig. 1) or in glutathione defi- 
ciency induced by the administering buthionine sulfoximine [22] 
or by starvation [23] can be a compensatory mechanism. Con- 
sidering the effect of ascorbate on the glutathione cycle in the 
liver, the protective effect of ascorbate [24] indicates that it can 
act as an essential antioxidant in glutathione deficiency. 
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